Pincement des marges au 1er semestre
• Le résultat net semestriel baisse de 16% avec un pincement de la marge d’exploitation. La structure financière est solide avec une trésorerie nette en progression.• Dans un contexte français compliqué, le management revoit en baisse son objectif de croissance à deux chiffres sur 2024 mais confirme l’amélioration de sa profitabilité. Nous abaissons nos prévisions.
• La méthode des DCF fait ressortir à une valorisation fondamentale de 4,9 € par action (vs 5,7 €).
UV Germi SA. UV Germi SA, formerly Bordas Uv Germi SA, is a France-based company engaged in the development of ultraviolet (UV) disinfection technology. It develops and manufactures a range of UV sterilizers for water treatment. Its sterilizers consist of low pressure mercury vapor lamps, which emit a monochromatic wavelength aimed at destruction of microorganisms. The lamps placed either in cylindrical tubes or canalization, with thin layers of water circulating around them and water components absorbing UV radiation. The applications of the Company's technology include dechloramination of swimming pools, treatment of drinking, rain and waste water, fountains and ponds disinfection, industrial water treatment, aquarium cleaning, and air treatment, purification and disinfection, among others.
Founded in 2016, CLEME FINANCE provides independant financial analysis for Small & Mid Caps and consulting in several areas (business valuation, business plan establishment...).
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.